By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


Company News
AEterna Zentaris (AEZS) Mails Management Information Circular In Connection With Annual Meeting Of Shareholders 4/3/2017 8:30:47 AM
AEterna Zentaris (AEZS) Intends To File NDA With Respect To Macrilen In Third Quarter Of 2017 3/30/2017 7:20:32 AM
AEterna Zentaris (AEZS) Announces At The Market Issuance Program 3/29/2017 7:02:07 AM
AEterna Zentaris (AEZS) Reports Fourth Quarter And Full-Year 2016 Financial And Operating Results 3/16/2017 6:59:08 AM
AEterna Zentaris (AEZS) Announces EMA Pediatric Committee Agreement On The Pediatric Investigation Plan For Macrilen 3/7/2017 8:41:02 AM
AEterna Zentaris (AEZS) To Announce Fourth Quarter And Full-Year 2016 Financial And Operating Results On March 15, 2017 3/6/2017 7:21:48 AM
AEterna Zentaris (AEZS) Announces Presentation Regarding Macrilen At 99th Annual Meeting Of The Endocrine Society 3/3/2017 6:47:58 AM
AEterna Zentaris (AEZS) Announces Zoptrex Presentation In Prostate Cancer At 2017 Genitourinary Cancers Symposium 2/15/2017 6:33:37 AM
AEterna Zentaris (AEZS) Announces Plans To Pursue FDA Registration Of Macrilen 2/13/2017 6:17:40 AM
AEterna Zentaris (AEZS) Announces Completion Of Zoptrex Pivotal Phase 3 Clinical Trial In Advanced Endometrial Cancer; Expects To Report Top-Line Results In April 2017 1/31/2017 11:26:54 AM